August 16, 2023 Comments Off on Drug Patent Expirations for the Week of August 13, 2023 Posted in: Uncategorized
ZERIT XR (stavudine) Bristol myers squibb Patent: 7,135,465 Expiration: Aug 18, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations for the…
August 16, 2023 Comments Off on New patent for Pfizer drug IBRANCE Posted in: Patent Added Annual Drug Patent Expirations for IBRANCE Ibrance is a drug marketed by Pfizer and is included in two NDAs. It is available from two suppliers. There are six patents protecting…
The post New patent for Pfizer drug IBRANCE appeared first on DrugPatentW…
